(3.135.201.209)
Users online: 6820     
Ijournet
Email id
 

Asian Journal of Pharmaceutical Analysis
Year : 2023, Volume : 13, Issue : 3
First page : ( 217) Last page : ( 221)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.52711/2231-5675.2023.00035

Analytical Review on Escitalopram oxalate and their combinations in Bulk and Pharmaceutical Formulation

Marathe Dinesh B., Koli Rohini M., Mahajan Kunal S., Dr. Patil R. R., Chaure Vinod A.*

Department of Pharmaceutical Chemistry, J.E.S’s College of Pharmacy, Nandurbar, 425412, Maharashtra, India

*Corresponding Author E-mail: vinodchaure1992@gmail.com

Online Published on 03 October, 2023.

Abstract

As an antidepressant, escitalopram oxalate, a pure S-enantiomer derivative of citalopram, blocks selective serotonin reuptake. By preventing serotonin reuptake and boosting serotonin levels in synaptic clefts, this action exerts an antidepressant effect. The analytical method used to identify Escitalopram oxalate in pharmaceutical formulations, both alone and in combination with other antidepressants, was identified in this review. The simultaneous comparison and discussion of eighteen analytical techniques, including HPLC, HPTLC, stability-indicating strategies, UV spectroscopy, hyphenated techniques and bioanalytical procedures, is best demonstrated by this thorough analysis. Analytical development must be validated in order to produce reliable results for regulatory filings. The invention of drugs resulted in a revolution in human health.

Top

Keywords

Escitalopram, Escitalopram oxalate, Review Article, Analytical Methods.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
752,443,052 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.